A Review on Novel Drug Delivery System: A Recent Trend
Plants are nature’s remedies and have been used by human beings on earth since ancient times for food and medicine. Today there are global movements towards finding of herbal medicaments in plants to bring them in market via a suitable drug delivery system for mankind. The basic thought behind it is treatment of each disease is hidden in nature. However, delivery of herbal drugs also requires modification with the purpose to achieve sustain release, to increase patient compliance etc. previously herbal drugs could not attract scientists towards the modifications of novel drug delivery systems due to processing, standardizing, extracting and identification difficulties. But now days with the advancement in the technology, novel drug delivery systems (NDDS) open the door towards the development of herbal novel drug delivery system. With use of advance techniques protection from toxicity, enhancement in stability, improved bioavailability of herbal formulations, protection from physical and chemical degradation can be achieve. Novel drug delivery technologies have gained the importance to achieve modified delivery of herbal drugs their by increasing the therapeutic value as well as reducing toxicity. The main goal for developing such delivery systems is to minimize drug degradation and loss, to prevent harmful side effects and to increase bioavailability. Targeting is the ability to direct the drug loaded system to the site of interest. Among drug carrier one can name soluble polymers, microparticles made of insoluble (or) biodegradable natural and synthetic polymers, microcapsules, cells, cell ghosts, lipoproteins, liposomes and micelles. Two major mechanisms can be distinguished for addressing the desired sites for drug release, (a) Passive and (b) Active targeting. Controlled drug carrier systems such as micellar solutions, vescicles and liquid crystal dispersions, as well as nanoparticle dispersions consisting of small particles of 10 – 400 nm show great promise as drug delivery systems. Hydrogels are three dimensional, hydrophilic, polymer networks capable of imbibing large amounts of water or biological fluids.
2. Atram S. Recent development of herbal formulation-a novel drug delivery system. International Ayurvedic Medical Journal, 2014; 2(6):952-58.
3. Alexis F, Basto P, Levy NE, Radovic MAF, Zhang LF, Pridgen E, et al. HER-2-Targeted Nanoparticle AntiibodyBioconjugates for Cancer Therapy. Chem Med Chem, 2008; 3:1839- 43.
4. Atmakuri LR, Dathi S. Current trends in herbal medicines. J Pharm Res., 2010; 3:109-113.
5. Niculescu-Duvaz I, Springer CJ. Antibody-directed enzyme prodrug therapy (ADEPT): a review.Advanced Drug Delivery Reviews 1997; 26:151-72.
6. Manabe T, Okino H, Maeyama R, Mizumoto K, Nagai E, Tanaka M, Matsuda T. Novel strategictherapeutic approaches for prevention of local recurrence of pancreatic cancer after resection: trans tissue, sustained local drug-delivery systems. Journal of Controlled Release 2004; 100:317-30.
7. Ziaie B, Baldi A, Lei M, Gu Y, Siegel RA. Hard and Soft Micro machining for Biomems. Review of Techniques and Examples of Applications in Microfluidics and Drug Delivery. Advanced DrugDelivery Reviews 2004; 56:145-72.
8. Muller RH, Runge SA. Solid lipid nanoparticles (SLN) for controlled drug delivery. In: Benita S, editor. Submicron emulsions in drug targeting and delivery. Harwood Academic Pub, 1998; 22(7):219-234.
9. Jain NK. Controlled and Novel drug delivery, 4th edition, New Delhi: CBS Publishers and Distributers, 2002, 236- 237.
10. Amin T, Bhat SV. A Review on Phytosome Technology as a Novel Approach to Improve the Bioavailability of Nutraceuticals. International Journal of Advancements in Research and Technology, 2012; 1(3):1-15.
11. Hikino H, Kiso Y, Wagner H, Fiebig M. Antihepatotoxic actions of flavonolignans from Silybummarianumfruits. Planta Med, 1984; 50:248-50.
12. Vishvakrama P, Sharma S, Liposomes: An Overview. Journal of Drug Delivery and Therapeutics, 2014; 47-55.
13. Khar RK, Jain NK. Solid lipid nanoparticle as Novel Nanoparticle system in Targeted and controlled drug delivery. IJPR, 102-103.
14. Chaturvedi M, Kumar M, Sinhal A, AlimuddinSaifi. Recent development in novel drug delivery systems of herbal drugs. International journal of Green Pharmacy, 2011; 5:87-94.
15. Kharat A, Pawar P. Novel drug delivery system in herbals. IJPCBS, 4, 2014, 910-930.
17. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymericnanoparticles as drug delivery devices. Journal of Controlled Release, 2001; 70:1-20.
18. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro andnanoparticles in drug delivery. Journal of Controlled Release 2004; 100:5-28.
19. Manach C, Scalbert A, Morand C, Remesy C and Jimenez L. Polyphenols: food sources and bioavailability. Am J ClinNutr, 2004; 79:727-747.
20. Jumaa M and Muller BW. Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: Mechanism of protective effect. Eur J Pharm Sci, 2009; 9:285-290.
21. Cui F, Wang Y, Wang J, Feng L, Ning K. Preparation of an entericsoluble solid-state emulsion using oily drugs. Int J Pharma, 2007; 338:152-6.
22. Scarfato P, Avallone E, Iannelli P, Aquino RP. Qucertin microsphere by solvent evaporation: preparation characterization and release behavior. J Appl Polymer Sci, 2008; 109:2994-3001.
23. Rastogi V, Shukla S, Singh R, Lal N, Yadav P, Microspheres: A Promising Drug Carrier. Journal of Drug Delivery and Therapeutics, 2016; 6(3):18-26.
24. Jaiswal P, Kesharwani S, Kesharwani R, Patel D, Ethosome: A New Technology Used As Topical & Transdermal Delivery System. Journal of Drug Delivery and Therapeutics, 2016; 6(3):7-17.
25. Saupe, Anne; Rades, Thomas (2006). "Solid Lipid Nanoparticles". Nanocarrier Technologies. p. 41. doi:10.1007/978-1-4020-5041-1_3. ISBN 978-1-4020-5040-4.
26. Jenning, V; Thünemann, AF; Gohla, SH. "Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids". International Journal of Pharmaceutics. 2000; 199(2):167–77. PMID 10802410.
27. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation. Rawat MK, Jain A and Singh S, Journal of Pharmaceutical Sciences, 2011; 100(6):2366-2378
28. Hunter CA. Vesicular System (Niosomes and Liposomes) for Delivery of Sodium Stibogluconate in Experimental Murine Visceral Leishmaniasis. J Pharm Pharmacol, 1988, 161-164.
29. Manach C, Scalbert A, Morand C, Remesy C and Jimenez L. Polyphenols: food sources and bioavailability. Am J ClinNutr, 2004; 79:727-747.
30. Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, and Piccerelle, P. Int.J. Pharm 2005; 292:1-2, 29-41.
31. Yoshio K, Masazumi K, Shuichi A, and Hiroaki N, J. Control. Release, 2005; 105(1-2):16-22.
32. Prajapati S, Maurya S, Das M, Tilak V, Verma K, & Dhakar R. Dendrimers in Drug Delivery, Diagnosis and Therapy: Basics and Potential Applications. Journal of Drug Delivery and Therapeutics, 2016; 6(1):67-92.
33. Muller Goymann CC. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Europ J of Pharmaceutics and Biopharmaceutics, 2004; 58(1):343-356.
34. Karaman R. The Future of Prodrugs Designed by Computational Chemistry. Drug Des. 2012; 1:1.
35. Harshal Ashok Pawar, BhagyashreeDilipBhangale. Phytosome as a Novel Biomedicine: A Microencapsulated Drug Delivery System. J Bioanal Biomed. 2015; 7:1.
36. Vandermeulen GM, Klok HA. Peptide/Protein Hybrid Material: Enhanced Control of Sructurenad Improved Performance through Conjugation of Biological and Synthetic Polymers. Macromolecular Bioscience 2003; 4:383-98.
37. Sood A and Panchagnula R. Peroral Route: An Opportunity for Protein and Peptide Drug Delivery.Chemical Reviews 2000; 101:3275-303.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).